参考文献/References:
[1] 昊林生,金嫣莉.膝痛[M].北京:人民卫生出版社,2010:347.
[2] ANDRIACCHI T P,FAVRE J,ERHART-HLEDIK J C,et al.A systems view of risk factors for knee osteoarthritis reveals insights into the pathogenesis of the disease[J].Annals of Biomedical Engineering,2015,43(2):376-387.
[3] TANG X,WANG S,ZHAN S,et al.The prevalence of symptomatic knee osteoarthritis in China results from the China health and retirement longitudinal study[J].Arhrritis Rheumatol,2016,68(3):648-653.
[4] 王斌,邢丹,林剑浩.骨关节炎诊治指南的临床转化应用[J].中华关节外科杂志:电子版,2017,11(1):104-108.
[5] 国家食品药品监督管理局.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:115-119.
[6] ALTMAN R,ASCH E,BLOCH D,et al.Development of criteris for the classification and reporting of osteoarthritis,classification of knee[J].Arthritis Rheum,1986,29(8):1039-1049.
[7] 阎小萍.常见风湿病及相关骨科疾病中西医结合诊治[M].北京:人民卫生出版社,2015:39.
[8] MATZKIN E G,CURRY E J,KONG Q,et al.Efficacy and treatment response of intra-articular corticosteroid injections in patients with symptomatic knee osteoarthritis[J].J Am Acad Orthop Surg,2017,25(10):703-714.
[9] 陈文锦,华臻,周智毅,等.关节腔内注射氧-臭氧治疗膝骨关节炎的临床疗效[J].江苏医药,2019,45(1):31-34.
[10] KO W,SOHN J H,JANG J H,et al.Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4 MyD88 mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide stimulated RAW264.7 and BV2 cells[J].Chem Biol Interact,2016,244:16.
[11] 苏晓恩,孔志强,朱娟,等.膝关节骨关节炎软骨中YKL-40、IL-1β的表达及相关性探讨[J].重庆医学,2017,46(4):480-482.
[12] 殷松江,邢润麟,王培民.基于TRP离子通道谈“以痛为枢、截断扭转”理论诊治膝骨关节炎的分子机制[J].中华中医药学刊,2018,36(11):2655-2658.
[13] 刘恒平,方心,薛斌,等.尪痹制剂与非甾体抗炎药对比治疗膝骨关节炎的随机对照试验的系统评价[J].河北中医,2017,39(2):180-184.
[14] 田镭,钟琴,马武开,等.独活寄生汤治疗膝骨关节炎的研究进展[J].风湿病与关节炎,2019,8(1):66-68.
[15] 申海艳,周静.中医外治法治疗膝骨关节炎的研究进展[J].风湿病与关节炎,2018,7(12):64-67.
[16] 赵颖林,张满成,李延红,等.活络止痛软膏治疗膝骨关节炎49例[J].中国中医骨伤科杂志,2013,21(10):43-44.
[17] 李延红,张宏蕾,石耀武,等.活络止痛软膏治疗膝骨关节炎60例[J].中国中医骨伤科杂志,2014,22(10):36-37.